Brief: Kancera Signs License Agreement, Obtains Global Commercial Rights To Results From Fractal Study

Novakand Pharma AB

23/02/2024 07:35

Feb 23 (Reuters) - Kancera AB  KANC.ST :
    * SIGNS LICENSE AGREEMENT AND OBTAINS GLOBAL COMMERCIAL
RIGHTS TO
RESULTS FROM FRACTAL STUDY
    * HAS SIGNED A LICENSE AGREEMENT WITH UNIVERSITY OF
NEWCASTLE
    * IS GRANTED EXCLUSIVE GLOBAL COMMERCIAL RIGHTS TO RESULTS
FROM
FRACTAL STUDY, INCLUDING FULL OWNERSHIP OF A NEW CLINICAL USE
PATENT

Source text for Eikon:  ID:nMFN5Whsy1 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))